Clinical Trials Directory

Trials / Completed

CompletedNCT01491867

Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect

Evaluation of Continuous IOP Measurement and the Influence of Drug Induced IOP Decrease on the Measurement

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Semmelweis University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Continuous intraocular pressure (IOP) measurement with a contact lens sensor may provide more information on the drug-related IOP change than 24-hour IOP measurement with Goldmann applanation tonometry (GAT.

Detailed description

* Participants are washed ot from all glaucoma medication for 6 weeks * one eye per participant is investigated (study eye) * 24-h intraocular pressure (IOP) curve is obtained with Goldmann tonometry and Sensimed contact lens sensor tonometry twice, in 14 days * for Sensimed contact lens curves median values (in arbitrary units), for Goldmann applanation tonometry, mean and SD values are used to characterize the curves, for comparisions % changes are used for the corresponding time periods * treatment (travoprost 0.005% 1/day) is given to all eyes for 3 months 24-h Goldmann and Sensimed IOP curves are repeated * IOP curves are determined in arbitrary units and mmHg, respectively, and compared for reproducibility (untreated phase) and relative (%)change (untreated curve vs. under treatment curve) with both methods, respectively

Conditions

Interventions

TypeNameDescription
DRUGtravoprost 0.003%Instillation of travoprost 0.003% 1/die in both eyes for 3 months

Timeline

Start date
2011-12-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2011-12-14
Last updated
2013-03-22

Locations

2 sites across 1 country: Hungary

Source: ClinicalTrials.gov record NCT01491867. Inclusion in this directory is not an endorsement.